TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers

Mucosal Immunology

Volumn 7, Issue 3, 2014, Pages 730-740

  Yu, X ^a   Pappu, R ^a   Ramirez Carrozzi, V ^a   Ota, N ^a   Caplazi, P ^a   Zhang, J ^a   Yan, D ^a   Xu, M ^a   Lee, W P ^a   Grogan, J L ^a  

^a Department of Immunology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEATH RECEPTOR 3; INTERLEUKIN 25; INTERLEUKIN 33; PAPAIN; PROTEIN TL1A; UNCLASSIFIED DRUG; INTERLEUKIN 17; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; EX VIVO STUDY; HELMINTHIASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INNATE TYPE 2 LYMPHOID CELL; INTESTINE INFECTION; LYMPHOID CELL; MOUSE; MUCOSAL IMMUNITY; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LUNG; LYMPHOCYTE SUBPOPULATION; METABOLISM; MUCOSA; NIPPOSTRONGYLUS; PARASITOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; LUNG; LYMPHOCYTE SUBSETS; MICE; MICE, TRANSGENIC; MUCOUS MEMBRANE; NIPPOSTRONGYLUS; PAPAIN; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84899579332     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.92     Document Type: Article

References (38)

1. Spits., H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647-675 (2012).
2. Spits, H. et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunology 13, 145-149 (2013).
3. Chang, Y.J. et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631-638 (2011).
4. Monticelli, L.A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045-1054 (2011).
5. Moro, K. et al. Innate production of T(H)2 cytokines by adipose tissueassociated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463, 540-544 (2010).
6. Neill, D.R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370 (2010).
7. Saenz, S.A. et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 464, 1362-1366 (2010).
8. Price, A.E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489-11494 (2010).
9. Yasuda, K. et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl. Acad. Sci. USA 109, 3451-3456 (2012).
10. Vonarbourg, C. & Diefenbach, A. Multifaceted roles of interleukin-7 signaling for the development and function of innate lymphoid cells. Semin. Immunol. 24, 165-174 (2012).
11. Fort, M.M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995 (2001).
12. Fallon, P.G. et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203, 1105-1116 (2006).
13. Hoshino, K. et al. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J. Exp. Med. 190, 1541-1548 (1999).
14. Hardman, C.S., Panova, V. & McKenzie, A.N. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur. J. Immunol. 43, 488-498 (2012).
15. Kim, B.S. et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci. Transl. Med. 5, 170ra116 (2013).
16. Meylan, F, Richard, A.C. & Siegel, R.M. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Immunol. Rev. 244, 188-196 (2011).
17. Yamazaki, K. et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol.Genet. 14, 3499-3506 (2005).
18. Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010).
19. Meylan, F. et al. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol. 4, 172-185 (2011).
20. Shih, D.Q. et al. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads tomild intestinal inflammation and fibrosis. PLoS One 6, e16090 (2011).
21. Taraban, V.Y. et al. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol. 4, 186-196 (2011).
22. Jin, S. et al. TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFalpha, from CD3+CD161+ T cells to exacerbate gut inflammation. Mucosal Immunol. 6, 886-899 (2012).
23. Scanlon, S.T. & McKenzie, A. Type 2 innate lymphoid cells: new players in asthma and allergy. Curr. Opin. Immunol. 24, 707-712 (2012).
24. Mjosberg, J. et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37, 649-659 (2012).
25. Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634-648 (2012).
26. Maizels, R.M., Hewitson, J.P. & Smith, K.A. Susceptibility and immunity to helminth parasites. Curr. Opin. Immunol. 24, 459-466 (2012).
27. Halim, T.Y., Krauss, R.H., Sun, A.C. & Takei, F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36, 451-463 (2012).
28. Saenz, S.A., Taylor, B.C. & Artis, D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol. Rev. 226, 172-190 (2008).
29. Grogan, J.L. & Ouyang, W. A role for Th17 cells in the regulation of tertiary lymphoid follicles. Eur. J. Immunol. 42, 2255-2262 (2012).
30. Kim, M.Y. et al. Neonatal and adult CD4+ CD3-cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J. Immunol. 177, 3074-3081 (2006).
31. Fang, L, Adkins, B, Deyev, V & Podack, E.R. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 205, 1037-1048 (2008).
32. Meylan, F. et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79-89 (2008).
33. Pappu, B.P. et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp.Med. 205, 1049-1062 (2008).
34. Ni, J, Nolte, B, Arnold, A., Fournier, P. & Schirrmacher, V. Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence. Vaccine 27, 5480-5487 (2009).
35. Tang, T. et al. A mouse knockout library for secreted and transmembrane proteins. Nat. Biotechnol. 28, 749-755 (2010).
36. Mjosberg, J.M. et al. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12, 1055-1062 (2011).
37. Pishdadian, A, Varasteh, A.R. & Sankian, M. Type 2 innate lymphoid cells: friends or foes-role in airway allergic inflammation and asthma. J. Allergy 2012, 130937 (2012).
38. Yu, X. et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 10, 48-57 (2009).